Diagnostics

Guardant Health nabs FDA test approval for BI's new cancer drug

Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360 CDx.

Ben Adams Jun 12, 2026 9:47am

Roche garners EU approval on label expansions for dx platform

Jun 11, 2026 9:02am

multiple myeloma cells blood flow cancer blood cancer

Predicta links with Spanish university to offer blood cancer dx

Jun 11, 2026 8:13am

Roche sticks with €600M diagnostics investment in Germany

Jun 9, 2026 8:00am

IMU nabs $53M funding round to ‘decode’ the immune system

Jun 3, 2026 7:43am

Foundation Medicine tallies FDA nod for latest blood test

Jun 2, 2026 10:45am